Sep 22, 202639 minS0
In this podcast, we sit down with Dr. Yvonne Maldonado of Stanford University School of Medicine, a widely recognized leader in infectious diseases. Building on the conversation sparked by Dr. Maldonado’s plenary talk...
science
ToxChats©
Hosted by ACT ToxChats · science · EN
About this Podcast:
The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
32%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for ToxChats©.
Signup to Generate a PitchQuestions about ToxChats©
What is ToxChats© about?
The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.
Who hosts ToxChats©?
ToxChats© is hosted by ACT ToxChats. The show has published 53 episodes to date.
What has ToxChats© covered recently?
Recent episodes include "Infectious Disease Outbreaks and Disease Elimination in the 21st Century: Reflections from the 2025 ACT Plenary Speaker" (22 September 2026, 39 minutes), "Infectious Disease Outbreaks and Disease Elimination in the 21st Century: Reflections from the 2025 ACT Plenary Speaker" (22 September 2026, 39 minutes), and "Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern" (31 July 2026, 39 minutes).
How often does ToxChats© publish?
ToxChats© publishes roughly every few months, with episodes averaging 36 minutes across 53 episodes.
How hard is it to get booked on ToxChats©?
Booking probability for ToxChats© is 32%, and the host is rated Selective on guests. ToxChats© requires a Pod Score of 80 or higher. ToxChats©'s contact route on record: verified email.
Who should pitch ToxChats©?
The strongest fits for ToxChats© are Scientific Research & Development. ToxChats© has a science audience.
About the host
ACT ToxChats hosts ToxChats©, a science podcast with 53 episodes published.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
- Sep 22, 202639 min
In this podcast, we sit down with Dr. Yvonne Maldonado of Stanford University School of Medicine, a widely recognized leader in infectious diseases. Building on the conversation sparked by Dr. Maldonado’s plenary talk...
ToxChats©
Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern
Jul 31, 202639 minS0This episode of ToxChats is designed to offer listeners a practical and insightful overview of the waiver process for carcinogenicity studies in pharmaceutical development, with a focus on the ICH S1B and S1B(R1)...
ToxChats©
Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern
Jul 31, 202639 minThis episode of ToxChats is designed to offer listeners a practical and insightful overview of the waiver process for carcinogenicity studies in pharmaceutical development, with a focus on the ICH S1B and S1B(R1)...
- May 1, 202642 minS0
In this episode of ToxChats, hosts Lauren Walker and Sarah Benjamin sit down with the groundbreaking Donald Ingber—visionary scientist, engineer, and Founding Director of the Wyss Institute. Dr. Ingber shares how his...
View More
- Feb 27, 202643 minS0
In this episode, Tanya McDonnell and Hemraj Dodiya sit down with two highly regarded toxicologists, Ric Stanulis and Mary Ellen Cosenza, who transitioned from industry and currently work as consultants, either...
- Nov 7, 202534 minS0
In this episode, Aimee Altemus and Adelaide Frimpong speak with Dr. Gary Miller of Columbia University, a widely recognized leader in exposome research. Dr. Miller discusses how the exposome—the full spectrum of...
- Oct 15, 202546 minS0
In this compelling ToxChats podcast episode, hosts Kristin DeSouza and Michael Dorato speak with renowned drug development scientist Richard DiMarchi as he shares his deep understanding into the art and science of...
- Sep 30, 20251h 7mS0
Laid off—or worried you might be—and wondering what's next? In this episode, hosts Sunjay Sethi and Sarah Benjamin partner with the Early Career Professionals to demystify the post-layoff job search for early- to...
ToxChats©
Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development
Jul 17, 202530 minS0This podcast episode is designed to offer listeners a discussion about the FDA’s evolving stance on animal testing and exploring thoughts on its potential phase-out for monoclonal antibody (mAb) therapies. Hosted by Zac...
- Jul 7, 202535 minS0
In this episode, host Zac Lloyd engages with expert in the field Colleen Johnson to discuss critical considerations in designing in vivo nonclinical programs for dermal and topical products. Through this conversation we...
- Jun 23, 202528 minS0
In this episode, we speak with Jean-Philippe Therrien, a senior director of R&D, to discuss critical considerations in designing nonclinical programs for dermal and topical products. Through this conversation, we aim to...
- May 5, 202544 minS0
In this episode, Dr. Katie Sokolowski and Dr. Tanya McDonnell sit down with Dr. Jessica Graham, a leader in the fields of occupational toxicology and product quality. During our time together, we discuss the current...
- Apr 1, 202522 minS0
In this podcast, Dr. Derek Leishman discusses the development of regulatory guidance (ICH and GLP) for safety pharmacology studies. He follows this discussion with a conversation about nonclinical data predicting...
- Feb 3, 202526 minS0
This podcast is part of a series on the different career paths in the field of toxicology. In this episode, we interview Dr. Alex Eapen on his career path to his current position as the Director of R&D Scientific &...
ToxChats©
Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study
Dec 18, 202426 minS0Not every drug that has reached human clinical trials has needed preliminary nonclinical studies to demonstrate safety. This podcast episode is a case study for replacing the use of animals during the safety testing...
- Nov 4, 202446 minS0
This ToxChats© episode is part of a series on the different career paths in the field of toxicology. In this episode, we interview Dr. Marcus Delatte on his career path to his current position as the Vice President of...
- Sep 2, 202418 minS0
In this podcast, recent findings from toxicological studies on the emissions produced during fused filament fabrication (FFF) 3D printing are discussed. The use of low-cost FFF 3D printers is on the rise in households...
- Aug 16, 202427 minS0
This podcast is part of a series on different career paths in the field of toxicology. In this episode, Dr. Chuck Schwartz, PhD, DABT, shares the career path that led to his current position as the principal consulting...
- Jul 1, 202425 minS0
Drug-induced seizures are a major concern for central nervous system active pharmaceuticals during development. Currently, there are no guidelines for interrogating and mitigating seizure liability associated with new...
Recent guests
Recent guests on ToxChats©. Study who booked and why before you pitch.
D
Dr. Yvonne Maldonado
Stanford University School of Medicine
Best industries to pitch ToxChats© for
PitchCentric classifies ToxChats© under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like ToxChats©
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ